The availability of assays and biomarkers of immune reactivity might be very useful in tailoring immunosuppressive therapy to specific patient needs. In particular, the capability to predict ...

A recent study reveals that immunosuppression, or reduced immune response, in prostate cancer is associated with a ...

Synthetic suppressor T cells could improve treatment for organ transplants, type 1 diabetes, and other autoimmune conditions.

In stable kidney transplant patients, the extent of reactivity is inversely correlated with the amount of ongoing immunosuppression. [27] Again, validation of this assay in larger, more diverse ...